查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446524

腫瘤學中的人工智慧市場規模、佔有率、趨勢分析報告：按組件類型、按癌症類型、按應用、按最終用途、按地區、細分市場預測，2024-2030 年

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

腫瘤學領域的人工智慧市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球腫瘤領域人工智慧市場規模預計將達到191.7億美元，2024年至2030年複合年成長率為28.92%。

由於全球人口中癌症盛行率不斷上升，以及開發技術先進的產品來診斷、治療和分析癌症的需求不斷成長，預計該市場將大幅成長。例如，國際癌症研究機構（IARC）預測，2023年新患者將超過2,070萬例。此外，人工智慧對於實現早期檢測和降低死亡率至關重要，特別是透過有效的篩檢計畫。

由於生活方式的改變和人口老化等多種因素，新興市場的癌症盛行率正在增加。這些市場中癌症患者的迅速增加正在產生對腫瘤學人工智慧等先進技術的需求，以改善早期檢測、個人化治療和整體患者治療結果。例如，2024年1月，印度首個人工智慧精準腫瘤中心（POC）在班加羅爾阿波羅癌症中心開幕。該 POC 利用人工智慧提供的巨大可能性，幫助腫瘤學家、患者和看護者在指定時間內實現最佳結果。

人工智慧透過將多組體學分析的大量資料集與深度學習和高效能運算技術的最新發展相結合，正在改變腫瘤學領域。人工智慧的應用正在擴展到新的檢測、篩檢、診斷和分類方法、癌症基因組學表徵、腫瘤微環境分析、預後和預測生物標記評估、後續觀察和藥物發現策略。例如，2022 年 10 月，Model Medicines 啟動了一項腫瘤學計劃，重點是識別和開發針對兩個磊晶和致癌性標靶的療法，重點是在固態和骨髓惡性腫瘤中的應用。

市場上的主要企業正在建立合作夥伴關係和聯合研究，重點關注新產品開發，以協助早期癌症診斷，滿足不斷成長的需求，並加強開發平臺。策略已被採用。例如，2022年12月，Astra Zeneca與Clinicink合作推出肺癌AI計劃。該計劃旨在及早發現肺癌並支持有效治療方法的開發。

此外，2022 年 11 月，Google Health 與 iCAD 建立合作夥伴關係，致力於利用該公司的人工智慧技術改善乳癌篩檢。此外，許多公共和私人組織都專注於資助和投資基於人工智慧的腫瘤篩檢產品的研發。例如，2023 年 3 月，Artera 獲得了 9,000 萬美元的資金，用於推出和行銷 ArteraAI 前列腺測試，這是第一個為預測局部前列腺癌治療而開發的測試。

腫瘤學市場人工智慧報告亮點

  • 按組件類型分類，軟體解決方案領域預計在預測期內將以最快的複合年成長率成長。
  • 以癌症類型來看，攝護腺癌在人群中的盛行率正在不斷上升，預計在預測期內將以最快的複合年成長率成長。根據 CDC 發布的資料，在美國，每 100 名男性中就有 13 人患有前列腺癌。
  • 從應用來看，研發產業預計在預測期內將以有利的複合年成長率成長。這是由於製藥公司廣泛採用和融合先進的人工智慧演算法。
  • 從最終用途來看，醫院佔據市場主導地位，成長最快。這是因為越來越多的公司正在醫院共同開發或實施人工智慧驅動的癌症治療解決方案。
  • 由於政府的積極舉措和數位基礎設施的可用性為患者提供數位解決方案，北美主導了市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章：腫瘤學領域的人工智慧市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTEL分析
  • COVID-19 對腫瘤市場人工智慧的影響

第 4 章：腫瘤學中的人工智慧市場細分分析（按組成部分）

  • 定義和範圍
  • 組件細分儀表板
  • 2018-2030 年全球腫瘤市場人工智慧組件
  • 軟體解決方案
    • 軟體解決方案市場，2018-2030
  • 硬體
    • 硬體市場，2018-2030
  • 服務
    • 服務市場，2018-2030

第 5 章：腫瘤學中的人工智慧市場細分分析（按癌症類型）

  • 定義和範圍
  • 癌症類型細分儀表板
  • 2018年至2030年市場規模、預測與趨勢分析
  • 乳癌
    • 2018-2030 年乳癌市場估計與預測
  • 肺癌
    • 2018-2030 年肺癌市場估計與預測
  • 攝護腺癌
    • 2018-2030 年前列腺癌市場估計與預測
  • 大腸直腸癌
    • 2018年至2030年大腸癌市場估計與預測
  • 腦腫瘤
    • 2018年至2030年腦瘤市場估計與預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第 6 章：腫瘤學中的人工智慧市場細分分析（按應用）

  • 定義和範圍
  • 使用細分儀表板
  • 2018年至2030年市場規模、預測與趨勢分析
  • 診斷（病理學、癌症放射學）
    • 診斷
  • 放射線治療（放射線治療）
    • 放射治療
  • 研究與開發（藥物發現、開發過程等）
    • 研究與開發
  • 化療
    • 2018-2030 年化療市場估計與預測
  • 免疫療法
    • 2018-2030 年免疫治療市場估計與預測

第 7 章：腫瘤學中的人工智慧市場細分分析（按最終用途類型）

  • 定義和範圍
  • 最終用途細分儀表板
  • 2018年至2030年市場規模、預測與趨勢分析
  • 醫院
    • 醫院市場，2018-2030
  • 外科中心和醫療機構
    • 2018-2030 年手術中心和醫療機構市場估計和預測
  • 其他（製藥公司、研究機構、訓練中心）
    • 其他

第 8 章：腫瘤學中的人工智慧市場細分分析（按地區、組成部分、癌症類型、應用和最終用途）

  • 定義和範圍
  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場簡介
  • SWOT分析
  • 北美洲
    • 北美腫瘤人工智慧市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲腫瘤學人工智慧市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區腫瘤市場人工智慧，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲腫瘤市場人工智慧，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 中東和非洲腫瘤學人工智慧市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章腫瘤學人工智慧市場—競爭分析

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Azra AI
    • IBM
    • Siemens Healthcare GmbH
    • Intel Corporation
    • GE HealthCare
    • NVIDIA Corporation
    • Digital Diagnostics Inc.
    • ConcertAI
    • Median Technologies
    • PathAI
Product Code: GVR-4-68039-985-7

AI In Oncology Market Growth & Trends:

The global AI in oncology market size is expected to reach USD 19.17 billion by 2030, registering a CAGR of 28.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company's artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

AI In Oncology Market Report Highlights:

  • Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component
  • Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC
  • Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies
  • Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals
  • North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Component outlook
    • 2.2.2. Cancer type outlook
    • 2.2.3. Application outlook
    • 2.2.4. End-use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. AI In Oncology Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for early detection and classification of cancer
      • 3.2.1.1.1.Case study 1
      • 3.2.1.1.2.Case study 2
      • 3.2.1.2. Increasing prevalence of cancer
      • 3.2.1.2.1.Breast
      • 3.2.1.2.2.Barain & CNS
      • 3.2.1.2.3.Kidney
      • 3.2.1.2.4.Non-Hodgkin lymphoma
      • 3.2.1.2.5.Bladder
      • 3.2.1.2.6.Colon & rectum
      • 3.2.1.2.7.Prostate
      • 3.2.1.2.8.Case Study 3
      • 3.2.1.3. Rising adoption of precision medicine
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High procurement and implementation cost
      • 3.2.2.2. Lack of skilled workforce
      • 3.2.2.3. High impact of regulations
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
  • 3.4. Impact of COVID-19 on AI in Oncology Market

Chapter 4. AI In Oncology Market Segment Analysis, By Component, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Component Segment Dashboard
  • 4.3. Global AI In Oncology Market, by Component, 2018 to 2030
  • 4.4. Software Solution
    • 4.4.1. Software Solution Market, 2018 - 2030 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Hardware Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. AI In Oncology Market Segment Analysis, By Cancer Type, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Cancer Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. Breast Cancer
    • 5.4.1. Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Lung Cancer
    • 5.5.1. Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Prostate Cancer
    • 5.6.1. Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.7. Colorectal Cancer
    • 5.7.1. Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.8. Brain Tumor
    • 5.8.1. Brain tumor market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. AI In Oncology Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Diagnostics (Pathology, Cancer Radiology)
    • 6.4.1. Diagnostics (pathology, cancer radiology) market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Radiation Therapy (Radiotherapy)
    • 6.5.1. Radiation therapy (radiotherapy) market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Research & Development (Drug Design, Development Process, etc.)
    • 6.6.1. Research & development (drug design, development process, etc.) market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. Chemotherapy
    • 6.7.1. Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8. Immunotherapy
    • 6.8.1. Immunotherapy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. AI In Oncology Market Segment Analysis, By End-use Type, 2018 - 2030 (USD Million)

  • 7.1. Definitions and Scope
  • 7.2. End-use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4. Hospitals
    • 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.5. Surgical Centers & Medical Institutes
    • 7.5.1. Surgical centers & medical institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Others (Pharmaceutical Companies, Research Institutes & Training Centers)
    • 7.6.1. Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2018 - 2030 (USD Million)

  • 8.1. Definition & Scope
  • 8.2. Regional Market Share Analysis, 2023 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
  • 8.6. North America
    • 8.6.1. North America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.6.2. U.S.
      • 8.6.2.1. Key Country Dynamic
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. U.S. Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.6.3. Canada
      • 8.6.3.1. Key Country Dynamic
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. Canada Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.7. Europe
    • 8.7.1. Europe Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.2. Germany
      • 8.7.2.1. Key Country Dynamic
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Germany Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.3. UK
      • 8.7.3.1. Key Country Dynamic
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. UK Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.4. France
      • 8.7.4.1. Key Country Dynamic
      • 8.7.4.2. Regulatory Framework
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. France Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.5. Italy
      • 8.7.5.1. Key Country Dynamic
      • 8.7.5.2. Regulatory Framework
      • 8.7.5.3. Competitive Insights
      • 8.7.5.4. Italy Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.6. Spain
      • 8.7.6.1. Key Country Dynamic
      • 8.7.6.2. Regulatory Framework
      • 8.7.6.3. Competitive Insights
      • 8.7.6.4. Spain Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.7. Denmark
      • 8.7.7.1. Key Country Dynamic
      • 8.7.7.2. Regulatory Framework
      • 8.7.7.3. Competitive Insights
      • 8.7.7.4. Denmark Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.8. Sweden
      • 8.7.8.1. Key Country Dynamic
      • 8.7.8.2. Regulatory Framework
      • 8.7.8.3. Competitive Insights
      • 8.7.8.4. Sweden Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.7.9. Norway
      • 8.7.9.1. Key Country Dynamic
      • 8.7.9.2. Regulatory Framework
      • 8.7.9.3. Competitive Insights
      • 8.7.9.4. Norway Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.8. Asia Pacific
    • 8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.2. Japan
      • 8.8.2.1. Key Country Dynamic
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. Japan Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.3. China
      • 8.8.3.1. Key Country Dynamic
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. China Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.4. India
      • 8.8.4.1. Key Country Dynamic
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. India Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.5. South Korea
      • 8.8.5.1. Key Country Dynamic
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. South Korea Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.6. Australia
      • 8.8.6.1. Key Country Dynamic
      • 8.8.6.2. Regulatory Framework
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Australia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.8.7. Thailand
      • 8.8.7.1. Key Country Dynamic
      • 8.8.7.2. Regulatory Framework
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Thailand Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.9. Latin America
    • 8.9.1. Latin America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.9.2. Brazil
      • 8.9.2.1. Key Country Dynamic
      • 8.9.2.2. Regulatory Framework
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. Brazil Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.9.3. Mexico
      • 8.9.3.1. Key Country Dynamic
      • 8.9.3.2. Regulatory Framework
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Mexico Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.9.4. Argentina
      • 8.9.4.1. Key Country Dynamic
      • 8.9.4.2. Regulatory Framework
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. Argentina Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
  • 8.10. MEA
    • 8.10.1. MEA Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.2. South Africa
      • 8.10.2.1. Key Country Dynamic
      • 8.10.2.2. Regulatory Framework
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. South Africa Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.3. Saudi Arabia
      • 8.10.3.1. Key Country Dynamic
      • 8.10.3.2. Regulatory Framework
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.4. UAE
      • 8.10.4.1. Key Country Dynamic
      • 8.10.4.2. Regulatory Framework
      • 8.10.4.3. Competitive Insights
      • 8.10.4.4. UAE Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
    • 8.10.5. Kuwait
      • 8.10.5.1. Key Country Dynamic
      • 8.10.5.2. Regulatory Framework
      • 8.10.5.3. Competitive Insights
      • 8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)

Chapter 9. AI In Oncology Market - Competitive Analysis

  • 9.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Profiles
    • 9.3.1. Azra AI
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. IBM
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Siemens Healthcare GmbH
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Intel Corporation
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. GE HealthCare
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. NVIDIA Corporation
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Digital Diagnostics Inc.
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. ConcertAI
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Median Technologies
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. PathAI
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 5 Global AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 6 Global AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 10 North America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 11 North America AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 14 U.S. AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 16 U.S. AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Canada AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 18 Canada AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 20 Canada AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Europe AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 22 Europe AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 23 Europe AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 25 Europe AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Germany AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 27 Germany AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 29 Germany AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 UK AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 31 UK AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 33 UK AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 France AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 35 France AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 36 France AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 37 France AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Italy AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 39 Italy AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 41 Italy AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Spain AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 43 Spain AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 45 Spain AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 47 Denmark AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 49 Denmark AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 51 Sweden AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 53 Sweden AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Norway AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 55 Norway AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 57 Norway AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 China AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 64 China AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 65 China AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 66 China AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Japan AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 68 Japan AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 70 Japan AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 India AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 72 India AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 73 India AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 74 India AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 South Korea AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 76 South Korea AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 78 South Korea AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Australia AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 80 Australia AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 82 Australia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Thailand AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 84 Thailand AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 86 Thailand AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Latin America AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 88 Latin America AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 89 Latin America AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 91 Latin America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Brazil AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 93 Brazil AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 95 Brazil AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Mexico AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 97 Mexico AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 99 Mexico AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Argentina AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 101 Argentina AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 103 Argentina AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 104 MEA AI in oncology market, by region, 2018 - 2030 (USD Million)
  • Table 105 MEA AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 106 MEA AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 108 MEA AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 109 South Africa AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 110 South Africa AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 112 South Africa AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 UAE AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 118 UAE AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 120 UAE AI in oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait AI in oncology market, by component, 2018 - 2030 (USD Million)
  • Table 122 Kuwait AI in oncology market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
  • Table 124 Kuwait AI in oncology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 AI in Oncology Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 AI in oncology Market snapshot
  • Fig. 7 AI in oncology Market segment snapshot
  • Fig. 8 AI in oncology Market segment snapshot
  • Fig. 9 AI in oncology Market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2023)
  • Fig. 12 AI in oncology market dynamics
  • Fig. 13 Areas of interest most likely to benefit from AI in the next 10 years
  • Fig. 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
  • Fig. 15 Comparison between AI-integrated healthcare and traditional healthcare
  • Fig. 16 Porter's Analysis
  • Fig. 17 PESTEL Analysis
  • Fig. 18 AI in oncology market, component outlook key takeaways (USD Million)
  • Fig. 19 AI in oncology market: Component movement analysis, 2023 & 2030 (USD Million)
  • Fig. 20 Software solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Hardware market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
  • Fig. 24 AI in oncology market: Cancer type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 25 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Brain tumor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
  • Fig. 32 AI in oncology market: Application movement analysis, 2023 & 2030 (USD Million)
  • Fig. 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Research & development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 AI in oncology market, end-use outlook key takeaways (USD Million)
  • Fig. 39 AI in oncology market: End-user movement analysis, 2023 & 2030 (USD Million)
  • Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Surgical centers and medical institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
  • Fig. 45 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
  • Fig. 46 North America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Canada AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Fig.54 Key country dynamics
  • Fig. 56 Germany AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Fig.56 Key country dynamics
  • Fig. 58 Spain AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Japan AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 China AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 India AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Mexico AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 MEA AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key company categorization
  • Fig. 99 Heat map analysis, 2022 - 2023